-
2-Deoxy-D-glucose: Metabolic Workflow Guide
2026-09-15
Use 2-Deoxy-D-glucose to interrogate glycolytic dependence across immune, cancer, and viral models with endpoint-specific controls. This guide translates reference findings into practical dosing, co-culture, combination-treatment, and troubleshooting workflows.
-
Sex Differences in Angiotensin II Hypertension
2026-09-15
Xue, Pamidimukkala, and Hay used conscious-mouse telemetry to show that chronic angiotensin II produces substantially greater hypertension in males than females, while gonadectomy reverses much of this pattern. The study also links the sex difference to altered baroreflex control and sympathetic support of blood pressure, providing a framework for separating vascular, hormonal, and autonomic mechanisms.
-
L-Ornithine for Urea Cycle Assays
2026-09-14
L-Ornithine enables controlled studies of OTC activity, nitrogen disposal, and liver–brain metabolic signaling. This workflow-focused guide covers aqueous preparation, enzyme and cell assays, metabolomics integration, and troubleshooting for reproducible amino acid metabolism research.
-
Butylated Hydroxyanisole (BHA) Assay Workflows
2026-09-14
Build more controlled oxidative stress experiments with BHA by separating stock preparation, redox perturbation, and endpoint interpretation. This workflow also adapts stereochemical and orthogonal-validation lessons from peptide research to improve ROS detection, apoptosis studies, and inflammation research.
-
Lactate–GPR81 Signaling and Glucose Uptake
2026-09-13
A 2026 Cell Research study identifies L-lactate as an insulin-independent regulator of skeletal-muscle glucose uptake and defines a GPR81–FARP1–RAC1–GLUT4 pathway connecting exercise metabolism with glucose homeostasis. Genetic, pharmacological, metabolic, and human-association evidence supports GPR81 as a potential complementary target for metabolic research, while translation beyond the reported models remains unresolved.
-
WAY-100635 for Reliable 5-HT1A Assays
2026-09-12
Learn how WAY-100635 (SKU A3933) can strengthen 5-HT1A receptor pharmacology, cell-based mechanism studies, and interpretation of viability or functional assay results. This scenario-driven guide connects documented potency and formulation data with practical controls for reproducible neuroscience workflows.
-
Miniaturized Imaging of Mature iPSC-Derived Neurons
2026-09-12
Sharlow and colleagues developed a feeder layer-free, miniaturized assay for imaging mature human iPSC-derived cortical neurons at single-cell resolution. By optimizing culture conditions and image analysis, the study reduced neuronal clustering and edge effects while producing robust neurotoxicity screening performance, including detection of moxidectin.
-
BGJ398: A Context-Aware FGFR2 Research Guide
2026-09-11
BGJ398 (NVP-BGJ398) is a selective FGFR1/2/3 inhibitor for studying pathway-dependent cancer biology. This guide connects its oncology use with comparative developmental evidence to improve assay design, interpretation, and translational discipline.
-
PEGylated Iron Oxide Nanoparticles in the Liver
2026-09-11
This ACS Nano study separates the effects of iron oxide nanoparticle size and PEG chain length on hepatic distribution and cell-specific uptake. Its combination of 99mTc SPECT/CT with primary liver-cell assays shows that hepatocytes and stellate cells can contribute substantially to uptake, challenging the assumption that Kupffer cells dominate nanoparticle clearance.
-
Bradykinin Workflows for Vascular Research
2026-09-10
Build reproducible vascular, permeability, smooth-muscle, pain, and inflammation assays with Bradykinin as a controlled endothelium-dependent vasodilator. This workflow combines acute functional measurements with orthogonal imaging and molecular readouts, while emphasizing peptide handling and assay-specific troubleshooting.
-
LY294002 Workflows for PI3K Signaling Research
2026-09-10
Build cleaner PI3K pathway experiments with LY294002 by combining concentration-response testing, time-resolved phosphoprotein analysis, and orthogonal viability or autophagy readouts. Its reversible activity also makes it useful for separating pathway dependence from irreversible drug stress in cancer and neuroinflammation models.
-
NVP-BGJ398 Phosphate: FGFR Workflow Guide
2026-09-09
NVP-BGJ398 phosphate connects quantitative FGFR1–3 inhibition with practical cancer, chondrocyte, and tissue-level assays. This workflow explains how to match genotype, phospho-signaling, phenotype, and formulation choices while avoiding common interpretation errors.
-
SB 225002: A Receptor-Resolved IL-8 Assay Strategy
2026-09-09
SB 225002 enables receptor-resolved analysis of IL-8/CXCL8 biology in neutrophil chemotaxis and cancer-associated inflammation. This guide translates recent MRSA extracellular-vesicle findings into practical assay decisions while clarifying what CXCR2 blockade can—and cannot—establish.
-
Caspase-4 Colorimetric Assay Kit for Pyroptosis
2026-09-08
Turn inflammatory cell-death biology into a measurable enzyme readout with a rapid, plate-compatible workflow. The Caspase-4 Colorimetric Assay Kit is especially useful for connecting intracellular LPS responses, pyroptosis, and organelle-targeted cancer studies while preserving practical controls for interpretation.
-
BIIE 0246: Y2R Logic for Neural Assays
2026-09-08
BIIE 0246 is a potent neuropeptide Y Y2 receptor antagonist for separating presynaptic NPY signaling from downstream cardiac, metabolic, and behavioral effects. This article presents an assay-centered framework for interpreting Y2R inhibition alongside the adipose-neural mechanisms implicated in arrhythmia.